Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-α

被引:22
|
作者
Gerotto, M
Dal Pero, F
Sullivan, DG
Chemello, L
Cavalletto, L
Polyak, SJ
Pontisso, P
Gretch, DR
Alberti, A
机构
[1] Univ Padua, Dept Clin & Expt Med, I-35128 Padua, Italy
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA USA
关键词
clonal frequency analysis; HCV infection; IFN resistance; NS5A-ISDR;
D O I
10.1046/j.1365-2893.1999.00166.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Resistance of the hepatitis C virus (HCV) to interferon-alpha (IFN-alpha) therapy in patients with hepatitis C maybe genetically controlled by an IFN sensitivity-determining region (ISDR) within the non-structural 5A (NS5A) gene. To assess whether HCV 1b strains carrying a 'resistant' type of ISDR are selected during unsuccessful IFN therapy, we analysed the evolution of the NS5A quasispecies, as detected by the clonal frequency analysis technique, and of the ISDR sequence by nucleotide sequence determination, in 11 patients showing no virological response during two consecutive cycles of IFN-alpha therapy, IFN-resistant patients had a homogeneous ISDR quasispecies with sequences identical to those described as resistant-' or 'intermediate-' type ISDR, After retreatment with IFN, further selection towards a homogeneous viral population was observed and 10 out of 11 patients had only one variant of HCV with no or just one single amino acid mutation within the ISDR sequence, Treatment and retreatment with IFN was associated in our nonresponder patients with evolution of the ISDR quasispecies towards a rather homogeneous viral population carrying a conserved or minimally mutated ISDR motif, supporting the idea that this motif may be relevant for IFN resistance in HCV 1b-infected individuals.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 50 条
  • [21] Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment
    Xiang, Xiaogang
    Lu, Jie
    Dong, Zhixia
    Zhou, Huijuan
    Tao, Wanyin
    Guo, Qing
    Zhou, Xiaqiu
    Bao, Shisan
    Xie, Qing
    Zhong, Jin
    INFECTION GENETICS AND EVOLUTION, 2011, 11 (02) : 382 - 390
  • [22] Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection
    Komatsu, H
    Fujisawa, T
    Inui, A
    Miyagawa, Y
    Onoue, M
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (04) : 361 - 365
  • [23] Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli
    Huang, LY
    Sineva, EV
    Hargitta, MRS
    Sharma, SD
    Suthar, M
    Raney, KD
    Cameron, CE
    PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) : 144 - 153
  • [24] Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded
    Hanoulle, Xavier
    Verdegem, Dries
    Badillo, Aurelie
    Wieruszeski, Jean-Michel
    Penin, Francois
    Lippens, Guy
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 381 (04) : 634 - 638
  • [25] The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus
    Jones, Bradley R.
    Howe, Anita Y. M.
    Harrigan, P. Richard
    Joy, Jeffrey B.
    VIRUS EVOLUTION, 2018, 4 (01)
  • [26] Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production
    Brenndorfer, Erwin Daniel
    Brass, Anette
    Soderholm, Jonas
    Frelin, Lars
    Aleman, Soo
    Bode, Johannes Georg
    Sallberg, Matti
    GUT, 2012, 61 (04) : 589 - 596
  • [27] Differential pressure of intermittant interferon therapy on hepatitis C virus quasispecies in the envelope glycoprotein 2 and non-structural 5A genes.
    Polyak, SJ
    Hofgaertner, W
    Corey, L
    Carithers, RL
    Gretch, DR
    HEPATOLOGY, 1996, 24 (04) : 119 - 119
  • [28] The rinderpest virus non-structural C protein blocks the induction of type 1 interferon
    Boxer, Emma L.
    Nanda, Sambit K.
    Baron, Michael D.
    VIROLOGY, 2009, 385 (01) : 134 - 142
  • [29] No evidence for increased frequency of autoantibodies during interferon-β1b treatment of multiple sclerosis
    Kivisakk, P
    Lundahl, J
    von Heigl, Z
    Fredrikson, S
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (05): : 320 - 323
  • [30] Polymorphisms of Hepatitis C Virus Non-Structural Protein 5A and Core Protein and Clinical Outcome of Pegylated-Interferon/Ribavirin Combination Therapy
    El-Shamy, Ahmed
    Kim, Soo-Ryang
    Ide, Yoshi-Hiro
    Sasase, Noriko
    Imoto, Susumu
    Deng, Lin
    Shoji, Ikuo
    Hotta, Hak
    INTERVIROLOGY, 2012, 55 (01) : 1 - 11